bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
Go back to bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales| (NASDAQ: BIAF) | Delayed: 0.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.49 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $ | |||
| Volume | 197,437 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $ | |||
| Open | $0.06 | 52 Week Low | $ | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.06 | EPS | $ | |||
| Volume | 60 | |||||

